You are here: Home »
News
»
Case Study
»
Solid Phase Peptide Synthesis
»
What is Solid Phase Synthesis Peptide?
What is Solid Phase Synthesis Peptide?
Polypeptide synthesis on a solid support, a concept of originality pioneered by Robert Bruce M errifield in 1963, is a major breakthrough in peptide chemistry.
In solid phase synthesis, it is conventional to assemble peptide chains starting from the C-terminus.
First, a linker is introduced on the polymer carrier; then, the N-terminal protected amino acid reacts with the functional group of the linker;
then the temporary protecting group is removed and condensed with the next amino acid, and this step is repeated until synthesis is required The sequence;
finally, cleaves the covalent bond between the tether and the peptide chain, and removes the insoluble carrier from the dissolved product.
_1698384535_WNo_650d695.webp)
The solid phase synthesis method effectively avoids the cumbersome and time-consuming separation and purification steps necessary for liquid phase synthesis, and has remarkable advantages, and its application value is irreplaceable.
Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy & Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment&Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
15
2026 07
Sunresin Nuclear-Grade Ion Exchange Resin Passes Product Appraisal, Supporting Reliable Nuclear Power Water Chemistry Control
Sunresin has successfully passed the product appraisal for its domestically developed nuclear-grade ion exchange resin, marking an important milestone in the development of high-performance chemical materials for nuclear power applications.
14
2026 07
Sunresin and ChromaGenix Partner to Expand Global Access to AAV Purification Technologies
The cooperation is designed to expand access to advanced AAV purification technologies and provide stronger regional support for cell and gene therapy developers across Asia, Europe and the Americas.
26
2026 05
Sunresin Completes Strategic Investment in FENGXINZE to Further Expand Industrial Chromatography Business
Sunresin recently completed a strategic investment in FENGXINZE, further expanding its business footprint in industrial chromatography and strengthening its presence in the life science separation and purification sector.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit